MAFBO 100Z - goovetvn.com

  • vn
  • eg

MAFBO 100Z

Lượt xem : 1561
Contact

Product Information

Reg No.: GOV-03

Trade name: MAFBO 100Z

Dosage form: Solution for injection.

Composition: Each 100 ml contains:

Marbofloxacin: 10 g

Excipients qs: 100ml

Indications

Treatment of respiratory infections caused by sensitive strains of Pasteurella multocida (pneumonic pasteurellosis in cattle), Mannheimia (Pasteurella) haemolytica, and Mycoplasma bovis.

Treatment of acute mastitis caused by E. coli strains sensitive to Marbofloxacin during lactation.

Treatment of mastitis, metritis, and milk fever caused by bacteria sensitive to Marbofloxacin.

Contraindication: Do not use in animals with known hypersensitivity to components of the product.

Dose and administration

- Administer 1ml per 50kg body weight in a single daily injection via I.M, S.C, or I.V routes in cattle. Use continuously for 3-5 days.

- The injection can be repeated at intervals of 24 hours for up to 4 days in total.

Withdrawal period

- Milk for human consumption: 36 hours from the last treatment.

- Slaughtered for human consumption: 6 days from the last treatment.

Storage: Keep it in a cool dry place, protected from direct sunlight. Temperature not exceeding 30oC

FOR VETERINARY USE ONLY

Nhận tư vấn

Please free contact to us if you need any information more.

Full Name(*)
Trường bắt buộc

Phone
Invalid Input

Address
Invalid Input

Messages(*)
Trường bắt buộc

Submit

RELATED PRODUCTS

fe-b12-iraq

fe-b12-iraq

Contact
BROM MAX

BROM MAX

Contact
TILMIKET PRO

TILMIKET PRO

Contact
DN 25

DN 25

Contact
GENTA 50

GENTA 50

Contact
B.COMPLEX COBAN

B.COMPLEX COBAN

Contact
KETO 1000

KETO 1000

Contact

CONTACT US

Goovet Group Joint Stock Company

-------------------------------

Address: Lot CN5, Thuy Van industrial Park, Nong Trang ward, Phu Tho province, Viet Nam

Tax Code: 2600 973 967

Hotline: (0210)3 555 855 – 3 555 955

Whatsapp - +84975918882

Email: [email protected]

Website: https://goovetvn.com/

 

 

Follow Youtube Channel

FOLLOW US

 

Newsletter